Company
CEO, Board Member
2015-01-01–present
CEO
Board Member
Emergent BioSolutions Inc. (EBS)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Recorded current and former roles; source labels appear when available.
2026-01-01–present
Organization not stated
CEO
Proxy statement
Organization not stated
Board Member
Proxy statement
2015-01-01–2026-05-11
Organization not stated
Board Member
Proxy statement
2015-01-01–2026-05-11
Organization not stated
CEO
Proxy statement
Start not stated–2023-11-07
Recorded roles and earnings-call appearances connecting this person to public companies.
Company
CEO, Board Member
2015-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | — | Former Chief Executive Officer | $517,316 | $4,830,882 |
| 2022 | — | Former Chief Executive Officer | $575,000 | $6,193,511 |
| 2021 | — | Chief Executive Officer | $567,000 | $5,645,417 |
| 2020 | — | Chief Executive Officer | $546,000 | $1,265,683 |
| 2019 | — | Chief Executive Officer | $525,000 | $3,532,024 |
| 2018 | — | Chief Executive Officer | $460,000 | $1,800,543 |
Earnings-call appearances and filed executive appointments or departures, newest first.
Kezar Life Sciences, Inc. Q2 FY2020 Earnings Call